Mauricio Garcia Saenz de Sicilia

Associate Professor

UAMS

Internal Med, College of Medicine

2 h-index 10 pubs 8 cited

Research Areas

Biomedical Subjects

Links

UAMS TRI Profile

OverviewAI-generated summary

Dr. Mauricio Garcia Saenz de Sicilia's research focuses on liver disease and transplantation, with a particular emphasis on patient outcomes and disparities. He investigates factors influencing liver transplant eligibility and success, including the impact of socioeconomic status and gender. His work also explores the prediction and management of complications associated with chronic liver disease, such as esophageal varices and portal hypertension.

Dr. Garcia has published on a range of topics within gastroenterology and hepatology, including the role of artificial intelligence in the field, non-alcoholic fatty liver disease, and drug-induced liver injury. He has also examined specific patient populations, such as those with inflammatory bowel disease undergoing liver transplantation and the outcomes in lean versus non-lean metabolic dysfunction-associated steatotic liver disease patients.

His publications include a meta-analysis and systematic review, reflecting a commitment to synthesizing existing evidence. Dr. Garcia's research network includes several collaborators from the University of Arkansas for Medical Sciences.

Research Overview

Dr. Mauricio Garcia joined the Division of Gastroenterology and Hepatology in the UAMS Department of Internal Medicine after completing an advanced fellowship in advanced transplant hepatology at the University of Nebraska. He received his medical degree from the University of National Autonomy of Mexico and completed his residency in internal medicine and a fellowship in gastroenterology from there as well. He is board certified in internal medicine and gastroenterology.

Metrics

h-index: 2
Publications: 10
Citations: 8

Selected Publications

Porto Sinusoidal Vascular Disorder Manifesting as Diffuse Arterio-Portal Fistulae and Portal Hypertension After Donation-After-Circulatory-Death Liver Transplantation (2026)

ACG Case Reports Journal DOI OpenAlex
The role of artificial intelligence in gastroenterology: current perspectives and future directions—narrative review (2026)

Translational Gastroenterology and Hepatology 5 citations DOI OpenAlex
Predicting Esophageal Varices and Varices Needing Treatment in Compensated Advanced Chronic Liver Disease (2025)

Digestive Diseases and Sciences 4 citations DOI OpenAlex
A Systematic Review and Meta-Analysis of Liver Transplant Outcomes in Lean Versus Non-Lean Metabolic Dysfunction-Associated Steatotic Liver Disease Patients (2025)

ASIDE Gastroenterology DOI OpenAlex
Non-alcoholic fatty liver disease and drug induced liver injury: A metabolic storm waiting to happen (2025)

World Journal of Hepatology 1 citation DOI OpenAlex
S4862 Multifaceted Diagnostic Approach for Unexplained Anemia in a Post Liver Transplant Patient With Metastatic Adenocarcinoma and Roux-en-Y Gastric Bypass (2024)

The American Journal of Gastroenterology DOI OpenAlex
Women Referred for Liver Transplant Are Less Likely to Be Transplanted Irrespective of Socioeconomic Status (2023)

Transplant International 5 citations DOI OpenAlex
Spontaneous Hepatic Hemorrhage in the Setting of Hepatic Amyloidosis: An Unusual Presentation (2018)

The American Journal of Gastroenterology 1 citation DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

As listed on this researcher's institutional profile.

205952 A Phase 2, Double-Blind, Randomized Study Evaluating the Safety, Tolerability, and Efficacy of GS-4997 in Combination with Prednisolone versus Prednisolone Alone in Subjects with Severe Alcoholic Hepatitis (AH) Gilead Sciences, Inc. Principal Investigator